Panthera BioPartners, an experienced clinical research company which recruits patients for and runs clinical trials, is currently looking for healthy volunteers aged over 30, who have NOT had a COVID vaccination, to take part in a new COVID-19 vaccine trial at its clinic in Preston.
All participants will get a COVID vaccine AND reimbursement of £550
The trial is a COVID prevention trial which will compare Valneva’s inactivated vaccine, VLA2001, with AstraZeneca’s conditionally approved vaccine Vaxzeria. Valneva’s inactivated vaccine technology is well-established and has been used to protect against many infectious diseases, like seasonal flu, hepatitis A, polio, and rabies.
Unlike earlier COVID-19 vaccine trials, which involved a placebo dose, everyone involved in this study will receive two active vaccine doses. Those enrolled in the study over the age of 30 will receive two doses of either the Valneva vaccine, or the approved Oxford/AstraZeneca vaccine.
Participants aged 18 – 29 can be enrolled into the study to receive the Valneva vaccine and will not be offered the approved Oxford/AstraZeneca vaccine.
Volunteers eligible to take part in the clinical trial will receive:
Panthera has a strict COVID-19 protocol in place to minimise the risk of infection to its patients, volunteers, and staff. All Panthera trial participants will be kept separate from other patients wherever possible. Details of this will be explained to volunteers in more detail if they choose to take part.
“Every new vaccine is another weapon with which we can fight this pandemic and we are very pleased that we have been able to assist in these trials and that we are able to give people in Preston the opportunity to take part in such an important study. We have put in place strict procedures and PPE at all our sites across the UK to make sure that patients, volunteers, and staff are as safe as possible. It is vital that clinical trials continue to ensure that there are new medications available to prevent and treat, not only COVID-19, but the many other conditions which afflict so many people.”
Stuart Young, CEO – Panthera
People interested in finding out more, or who wish to take part in this COVID clinical trial, should contact the Panthera team and quote HUB: